NASDAQ: JSPR
Jasper Therapeutics Inc Stock Ownership - Who owns Jasper Therapeutics?

Insider buying vs selling

Have Jasper Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Svetlana LucasDirector2025-09-2220,000$2.43
$48.60kBuy
Ron MartellPresident and CEO2025-09-2241,000$2.43
$99.63kBuy
Judith Anne ShizuruDirector2025-09-2241,000$2.43
$99.63kBuy
Thomas G. WiggansDirector2025-09-2241,000$2.43
$99.63kBuy

1 of 1

JSPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JSPR insiders and whales buy or sell their stock.

JSPR Shareholders

What type of owners hold Jasper Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roche Holding Ltd32.78%9,174,212$13.58MInsider
Qiming Us Healthcare Fund II LP30.44%8,519,648$12.61MInsider
Barney A. Richmond23.10%6,464,048$9.57MInsider
Kurt Von Emster20.19%5,649,733$8.36MInsider
Abingworth LLP20.11%5,628,558$8.33MInsider
Velan Capital Investment Management LP9.54%2,668,395$3.95MInstitution
Howard I. Hoffen8.22%2,300,000$3.40MInsider
Kenneth F. Clifford8.22%2,300,000$3.40MInsider
Balaji Venkataraman8.22%2,300,000$3.40MInsider
Amplitude Healthcare Holdings LLC8.22%2,300,000$3.40MInsider

1 of 3

JSPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JSPR29.25%70.75%Net Buying
TVRD7.84%92.16%Net Selling
CVM4.07%95.93%Net BuyingNet Buying
OKUR28.70%71.30%Net SellingNet Selling
BTAI1.18%98.82%

Jasper Therapeutics Stock Ownership FAQ

Who owns Jasper Therapeutics?

Jasper Therapeutics (NASDAQ: JSPR) is owned by 72.03% institutional shareholders, 174.25% Jasper Therapeutics insiders, and 0.00% retail investors. Roche Holding Ltd is the largest individual Jasper Therapeutics shareholder, owning 9.17M shares representing 32.78% of the company. Roche Holding Ltd's Jasper Therapeutics shares are currently valued at $14.31M.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.